Jiage Ding

501 total citations
18 papers, 414 citations indexed

About

Jiage Ding is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jiage Ding has authored 18 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Jiage Ding's work include Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Jiage Ding is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Jiage Ding collaborates with scholars based in China, United States and India. Jiage Ding's co-authors include Qing Zhang, Mengmeng Lü, Huizhong Li, Hongyan Liu, Junnian Zheng, Liantao Li, Junnian Zheng, Gang Wang, Hailong Li and Dafei Chai and has published in prestigious journals such as International Journal of Biological Macromolecules, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer and Pharmacological Research.

In The Last Decade

Jiage Ding

17 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiage Ding China	11	300	227	128	60	50	18	414
Mengmeng Lü China	11	328 1.1×	207 0.9×	115 0.9×	87 1.4×	59 1.2×	15	447
Ronan Thibaut France	6	237 0.8×	195 0.9×	137 1.1×	68 1.1×	25 0.5×	7	428
Annika De Sousa Linhares Austria	7	270 0.9×	212 0.9×	95 0.7×	42 0.7×	42 0.8×	11	400
Irina Ganeeva Russia	9	216 0.7×	132 0.6×	130 1.0×	51 0.8×	27 0.5×	16	344
Hans Anton Schloesser Germany	5	247 0.8×	168 0.7×	136 1.1×	61 1.0×	89 1.8×	11	438
Lieke L. van der Woude Netherlands	6	212 0.7×	187 0.8×	77 0.6×	38 0.6×	42 0.8×	10	306
Erminia Romano Belgium	7	171 0.6×	201 0.9×	101 0.8×	115 1.9×	88 1.8×	8	412
Zhengtao Hong China	7	239 0.8×	222 1.0×	142 1.1×	78 1.3×	82 1.6×	9	458
Elisa Ruffo United States	7	250 0.8×	203 0.9×	131 1.0×	34 0.6×	61 1.2×	10	428
Jitske van den Bulk Netherlands	7	232 0.8×	196 0.9×	144 1.1×	27 0.5×	56 1.1×	7	383

Countries citing papers authored by Jiage Ding

Since Specialization

Citations

This map shows the geographic impact of Jiage Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiage Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiage Ding more than expected).

Fields of papers citing papers by Jiage Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiage Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiage Ding. The network helps show where Jiage Ding may publish in the future.

Co-authorship network of co-authors of Jiage Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Jiage Ding. A scholar is included among the top collaborators of Jiage Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiage Ding. Jiage Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wang, Jiawei, Bowen Lu, Yuchen Zhang, et al.. (2025). Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma. Journal for ImmunoTherapy of Cancer. 13(1). e010521–e010521. 1 indexed citations

Lu, Bowen, Liyuan Chai, Xin Jin, et al.. (2024). Co-immunization with IFI35 enhances the therapeutic effect of an adenovirus vaccine against renal carcinoma. International Journal of Biological Macromolecules. 286. 138515–138515.

Zheng, Yanyan, Fei Zhu, Bowen Lu, et al.. (2024). Therapeutic vaccine targeting dual immune checkpoints induces potent multifunctional CD8+ T cell anti-tumor immunity. International Immunopharmacology. 142(Pt A). 113004–113004. 1 indexed citations

Zhu, Fei, Wenjing Tang, Bowen Lu, et al.. (2024). Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors. Journal for ImmunoTherapy of Cancer. 12(8). e009869–e009869. 3 indexed citations

Ding, Jiage, Fei Zhu, Navid Sobhani, et al.. (2023). The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma. npj Vaccines. 8(1). 109–109. 5 indexed citations

Shi, Xiaoqing, Jiage Ding, Jiawei Wang, et al.. (2023). HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma. iScience. 26(3). 106143–106143. 12 indexed citations

Ding, Jiage, Yanyan Zheng, Fei Zhu, et al.. (2023). Adenovirus-assembled DC vaccine induces dual-targeting CTLs for tumor antigen and adenovirus to eradicate tumors. International Immunopharmacology. 123. 110722–110722. 5 indexed citations

Ding, Jiage, Nan Jiang, Jiawei Wang, et al.. (2022). Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8+ T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma. Cancers. 14(18). 4512–4512. 8 indexed citations

Ding, Jiage, Yanyan Zheng, Gang Wang, Junnian Zheng, & Dafei Chai. (2022). The performance and perspectives of dendritic cell vaccines modified by immune checkpoint inhibitors or stimulants. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1877(5). 188763–188763. 11 indexed citations

10.

Chai, Dafei, Navid Sobhani, Jiage Ding, et al.. (2022). IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent Autophagy. Cancers. 14(12). 2861–2861. 14 indexed citations

11.

Ding, Jiage, Nan Jiang, Yanyan Zheng, et al.. (2021). Adenovirus vaccine therapy with CD137L promotes CD8+ DCs-mediated multifunctional CD8+ T cell immunity and elicits potent anti-tumor activity. Pharmacological Research. 175. 106034–106034. 13 indexed citations

12.

Chai, Dafei, Xiaoqing Shi, Jiage Ding, et al.. (2021). Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity. Molecular Therapy — Oncolytics. 24. 1–13. 15 indexed citations

13.

Chai, Dafei, Nan Jiang, Jiage Ding, et al.. (2021). Co‐immunization with L‐Myc enhances CD8⁺ or CD103⁺ DCs mediated tumor‐specific multi‐functional CD8⁺ T cell responses. Cancer Science. 112(9). 3469–3483. 10 indexed citations

14.

Zhang, Qing, Hongyan Liu, Hanhan Wang, et al.. (2019). Lenvatinib promotes antitumor immunity by enhancing the tumor infiltration and activation of NK cells.. PubMed. 9(7). 1382–1395. 35 indexed citations

15.

Li, Huizhong, Jiage Ding, Mengmeng Lü, et al.. (2019). CAIX-specific CAR-T Cells and Sunitinib Show Synergistic Effects Against Metastatic Renal Cancer Models. Journal of Immunotherapy. 43(1). 16–28. 87 indexed citations

16.

Zhang, Qing, Jiage Ding, Shishuo Sun, et al.. (2019). Akt inhibition at the initial stage of CAR-T preparation enhances the CAR-positive expression rate, memory phenotype and in vivo efficacy.. PubMed. 9(11). 2379–2396. 41 indexed citations

17.

Zhang, Qing, Jǐnjīng Xǔ, Jiage Ding, et al.. (2018). Bortezomib improves adoptive carbonic anhydrase�IX‑specific chimeric antigen receptor‑modified NK92 cell therapy in mouse models of human renal cell carcinoma. Oncology Reports. 40(6). 3714–3724. 28 indexed citations

18.

Zhang, Qing, Jiage Ding, Hongyan Liu, et al.. (2018). Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models. Journal of Immunology Research. 2018. 1–11. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact